Bayer AG
![Bayer AG](https://api.admiralmarkets.com/trade_icons/bright-128/BAYN.png)
Suletud
Sektor Rahandus
28.935 -0.57
Ülevaade
Aktsiahinna muutus
24h
Min
28.91
Max
29.185
Sissetulek | -2B -34M |
---|---|
Müük | -2.6B 11B |
P/E Sektori keskmine | 30.9 19.92 |
Aktsiakasum | 0.94 |
Kasumimarginaal | -0.305 |
EBITDA | -2.6B 1.7B |
Soovitused | Neutraalne |
---|---|
12 kuu keskmine prognoos | +3.52 upside |
Turukapital | 182M 28B |
---|---|
Eelmine avamishind | 29.51 |
Eelmine sulgemishind | 28.935 |
Tehniline skoor
By Trading Central
Kindlus
Very Strong Bullish Evidence
Bayer AG Graafik
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Bayer AG Prognoos
Hinnasiht
By TipRanks
3.52% tõus
12 kuu keskmine prognoos
Keskmine 30 EUR 3.52%
Kõrge 34 EUR
Madal 26 EUR
Põhineb 10 Wall Streeti analüütiku instrumendi Bayer AG 12 kuu hinnasihil - viimase 3 kuu andmed.
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
EBITDA
Ärikasum
$
Ettevõttest Bayer AG
Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non